Paradigm Biopharmaceuticals Ltd
ASX:PAR
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Price:
0.305
AUD
1.67%
Market Closed
Market Cap:
AU$130.7m
Wall Street
Price Targets
PAR Price Targets Summary
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Wall Street analysts forecast PAR stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PAR
is 0.663 AUD
with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.
Lowest
Price Target
0.657
AUD
115% Upside
Average
Price Target
0.663
AUD
117% Upside
Highest
Price Target
0.683
AUD
124% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PAR's stock price target?
Price Target
0.663
AUD
0.663
AUD
According to Wall Street analysts, the average 1-year price target for
PAR
is 0.663 AUD
with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.
What is Paradigm Biopharmaceuticals Ltd's Revenue forecast?
Projected CAGR
185%
185%
For the last 10 years the
compound annual growth rate for
Paradigm Biopharmaceuticals Ltd's revenue is
99%.
The projected
CAGR
for the next 3 years is
185%.
